Griggio et al., 2020 reported an aberration in the tumor-suppressor gene TP53 that is also associated with higher expression level of HIF1α [24] which has an unfavorable prognosis in CLL patients [25]. Here, HIF1A is linked to B-cell chronic lymphocytic leukemia.